| Therapeutic DNA vaccination against colorectal cancer by targeting the MYB oncoprotein. | colorectal, |
| Transcription factor and microRNA interactions in lung cells: an inhibitory link between NK2 homeobox 1, miR-200c and the developmental and oncogenic factors Nfib and Myb. | lung, |
| Expression of the c-myb oncogene in human small cell lung carcinoma. | lung, |
| ZDHHC11 and ZDHHC11B are novel targets of miR-150 with a key role in maintaining elevated levels of the MYB oncogene required for the high proliferation rate of Burkitt lymphoma cells. | lymphoma, |
| Structural and functional domains of the myb oncogene: requirements for nuclear transport, myeloid transformation, and colony formation. | colorectal, |
| The c-Myb gene encodes a transcription factor that regulates cell proliferation, differentiation, and apoptosis through protein-protein interaction and transcriptional regulation of signaling pathways. The protein is frequently overexpressed in human leukemias, breast cancers, and solid tumors suggesting that it is a bona fide oncogene. c-MYB is often overexpressed by chromosomal translocation in human tumors. [review] | leukemia,breast, |
| Mechanism of activation of the myb oncogene in myeloid leukemias. | leukemia, |
| Mapping of amplified c-myb oncogene, sister chromatid exchanges, and karyotypic analysis of the COLO 205 colon carcinoma cell line. | colorectal, |
| Early decline in c-myb oncogene expression in the differentiation of human myeloblastic leukemia (ML-1) cells induced with 12-O-tetradecanoylphorbol-13-acetate. | leukemia, |
| Nucleotide sequence of the retroviral leukemia gene v-myb and its cellular progenitor c-myb: the architecture of a transduced oncogene. | leukemia, |
| Amplification of the c-myb oncogene in a case of human acute myelogenous leukemia. | leukemia, |
| Aberrant expression of an amplified c-myb oncogene in two cell lines from a colon carcinoma. | colorectal, |
| Differential expression of c-erbB, c-myc and c-myb oncogene loci in human lymphomas and leukemias. | lymphoma,leukemia, |
| DNA rearrangement and altered RNA expression of the c-myb oncogene in mouse plasmacytoid lymphosarcomas. | sarcoma, |
| Proviral activation of the c-myb proto-oncogene is detectable in preleukemic mice infected neonatally with Moloney murine leukemia virus but not in resulting end stage T lymphomas. | lymphoma,leukemia, |
| Induction of B cell lymphomas by overexpression of a Myb oncogene truncated at either terminus. | lymphoma, |
| Overexpression of C-terminally but not N-terminally truncated Myb induces fibrosarcomas: a novel nonhematopoietic target cell for the myb oncogene. | fibrosarcoma, |
| Retroviral insertional mutagenesis in murine promonocytic leukemias: c-myb and Mml1. | leukemia, |
| Myb-Ets fusion oncoprotein inhibits thyroid hormone receptor/c-ErbA and retinoic acid receptor functions: a novel mechanism of action for leukemogenic transformation by E26 avian retrovirus. | thyroid, |
| Retroviral insertional activation of the c-myb proto-oncogene in a Marek s disease T-lymphoma cell line. | lymphoma, |